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Zika virus RNA is frequently detected in the semen of men 
after Zika virus infection. To learn more about persistence of 
viruses in genital fluids, we searched PubMed for relevant 
articles. We found evidence that 27 viruses, across a broad 
range of virus families, can be found in human semen. 
The finding by Atkinson et al. that Zika virus RNA is fre-quently detected in the semen of men after infection (1) 
highlights our knowledge gaps regarding the persistence of 
viruses in genital fluids, especially semen. Replicating Zika 
virus (2), like Ebola and Marburg viruses (3), has been iso-
lated from semen and has been sexually transmitted. How-
ever, it is probable that many more viruses capable of caus-
ing viremia (presence of virus in the blood) can be found 
in semen. Seeding to the male reproductive tract may fre-
quently occur in the context of viremia because the blood–
testes/deferens/epididymis barriers are imperfect barriers 
to viruses, especially in the presence of systemic or local 
inflammation (4). Virus may persist even if incapable of 
replicating within the male reproductive tract because the 
testes are immunologically privileged (4); that is, within 
the testes, the immune response is restricted to enable the 
survival of sperm, which are immunogenic. Virus may also 
be transmitted to semen as a result of survival and replica-
tion within the accessory glands (5).
To investigate the breadth of viruses in semen, we per-
formed a PubMed search by using the terms “virus* AND 
semen OR sperm* OR seminal.” We imposed no date or 
language restrictions. This search returned 3,818 results. We 
screened the titles, abstracts, and full text articles for data 
that described detection of viruses in semen by nucleic acid 
amplification or detection, antigen detection, replication in 
cell culture, or replication in an animal system. We restrict-
ed the results to viruses capable of causing viremia. Where 
we found evidence for virus in semen, we then searched 
PubMed for evidence of sexual transmission by using the 
terms “(name of virus) AND sex* AND Transm*.” 
Our search revealed that 27 viruses that can result 
in viremia have been found in human semen (Table). For 
many of these, data on sexual transmission are lacking. 
Of these 27 viruses, many cause chronic or latent infec-
tion (e.g., HIV virus, cytomegalovirus). However, several 
cause acute infections, including Lassa fever, Rift Valley 
fever, and chikungunya viruses. Of those causing acute 
infections, only Zika and Ebola viruses have been sys-
tematically screened for in semen (i.e., in case series or 
cohort studies rather than case reports). These 27 viruses 
come from diverse families, suggesting that the presence 
of many viruses in semen is unlikely to be exclusively 
dependent on specific or conserved viral epitopes, ability 
of virus to replicate within the male reproductive tract, or 
common mechanisms of immune evasion. Other factors 
that may also influence whether viruses exist in semen are 
level of viremia, inflammatory mediators (altering blood-
barrier permeability), systemic immunosuppression, male 
reproductive tract immune responses, presence of sexu-
ally transmitted diseases, and virus structural stability. In 
mammals, numerous viruses are detectable in semen, in-
cluding viruses that can cause disease in humans, such as 
Japanese encephalitis virus, foot and mouth disease virus, 
parainfluenza virus, and paravaccinia virus (6). Several 
other viruses that result in viremia can cause orchitis and 
have been detected in human testes, suggesting the pos-
sibility that these viruses may also be detectable in semen. 
These viruses include influenza virus, lymphocytic cho-
riomeningitis virus, phlebotomus fever virus, cocksackie 
B virus, echovirus, dengue virus, systemic acute respira-
tory syndrome virus, parvovirus, smallpox virus, vaccinia 
virus, and rubella virus (7).
Given these findings, the following questions need to 
be addressed: which viruses are shed and remain viable 
in semen, for how long, and at what concentrations? The 
answers to these questions have implications for risks for 
sexual transmission and, therefore, embryonic infection, 
congenital disease, miscarriage, and effects on epidemio-
logic and transmission models. The presence of virus in 
the male reproductive tract may increase the risk for ac-
quisition of sexually transmitted infections and may reduce 
male fertility through spermatogonial stem cell infection or 
local inflammation. Infection of spermatozoa could result 
in transmission of virus-induced mutations to subsequent 
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generations, thereby elevating risks for cancer and other 
disorders. Indeed, when virus has been detected in human 
semen, the extent to which virus existence and replication 
occurs within spermatozoa is unclear (8). Not all therapeu-
tics will cross the male reproductive tract–blood barriers, 
and viruses may persist in semen despite systemic clear-
ance of virus, highlighting the need to consider the male 
reproductive tract–blood barriers when choosing therapeu-
tic agents in clinical trials. Virus within the male reproduc-
tive tract can also be genetically distinct from virus in other 
compartments, including blood (9), which has implications 
for gene-based vaccines and therapeutics.
The presence of viruses in semen is probably more 
widespread than currently appreciated, and the absence 
of virus in genital secretions should not be assumed for 
traditionally non–sexually transmitted viruses. The inves-
tigation of virus detection and persistence in semen across 
a range of viruses is useful for clinical and public health 
reasons, in particular for viruses that lead to high mortality 
or morbidity rates or to epidemics.
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Table. Viruses that are capable of causing viremia and found in human semen* 
Virus Family 
Detection in  
semen, maximum 
detection time, d 
Isolation from  
semen, maximum 
detection time, d 
Evidence for  
sexual transmission  
within same cohort 
Adenoviruses  Adenoviridae AD RCC Unknown 
Transfusion transmitted virus  Anelloviridae NAA No data found Unknown 
Lassa fever virus† Arenaviridae NAA, 103 RCC, 20 Unknown 
Rift Valley fever virus† Bunyaviridae NAA, 117 No data found Unknown 
Ebola virus Filoviridae NAA, 531 RCC, 82 Epi + mol + sem 
Marburg virus† Filoviridae AD, 83 RAS, 83 Epi + sem 
GB virus C  Flaviviridae NAA No data found Epi + mol 
Hepatitis C virus Flaviviridae NAA; AD No data found Epi + mol 
Zika virus Flaviviridae NAA, 188 RCC, 7 Epi + mol + sem 
Hepatitis B virus Hepadnaviridae NAA; AD RAS Epi + mol 
Cytomegalovirus Herpesviridae NAA RCC Epi + mol + sem 
Epstein Barr virus  Herpesviridae NAA No data found Epi and semen 
Human herpes virus 8  Herpesviridae NAA RCC Epi + mol 
Human herpes virus 7  Herpesviridae NAA No data found Unknown 
Human herpes virus 6  Herpesviridae NAA No data found Unknown 
Human simplex viruses 1 and 2  Herpesviridae NAA; AD RCC Epi + mol + sem 
Varicella zoster virus  Herpesviridae NAA No data found Unknown 
Mumps virus†  Paramyxoviridae NAA, 40 RCC, 14 Unknown 
Adeno-associated virus  Parvoviridae NAA RCC Unknown 
BK virus Polyomaviridae NAA No data found Unknown 
JC virus  Polyomaviridae NAA No data found Unknown 
Simian virus 40  Polyomaviridae NAA No data found Unknown 
HIV Retroviridae NAA; AD RCC Epi + mol + sem 
Human T-cell lymphoma virus 1† Retroviridae No data found RAS Epi + mol 
Simian foamy virus  Retroviridae NAA No data found Unknown 
Chikungunya virus† Togaviridae NAA, 30 No data found Unknown 
*Presence of nucleic acid or antigen in semen does not represent the presence of replication-competent or infection-competent virus, which can generally 
only be demonstrated by isolation and culture of virus. Maximum detection time refers to time from symptom onset (only in viruses that cause acute only, 
not chronic, infection). A complete table with references is provided in the online Technical Appendix (https://wwwnc.cdc.gov/EID/article/23/11/17-1049-
Techapp1.pdf). AD, antigen detection; Epi, epidemiologic evidence of sexual transmission; mol, molecular/phylogenetic evidence of sexual transmission; 
NAA, nucleic acid amplification or detection; RAS, replication in animal system; RCC, replication in cell culture; sem, isolation from semen.  
†Data found only in the context of case reports and not case series, case control, or cohort studies.  
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Proactive environmental surveillance for Legionella pneu-
mophila in hospitals that treat immunocompromised pa-
tients is a useful strategy for preventing nosocomial Legion-
naires’ disease. We report the presence of L. pneumophila 
serogroup 1 in 15.2% of the water systems of our tertiary 
healthcare center, which should prompt health officials to 
formulate mitigation policies.
Legionella pneumophila, the causative agent of Le-gionnaires’ disease (LD), is a bacterium omnipresent 
in aquatic environments and increasingly recognized as a 
major cause of community- and hospital-acquired pneumo-
nia. L. pneumophila serogroup 1 (Lp1), the dominant sero-
group, accounts for ≈84% of human infections worldwide 
(1,2). Hospital-acquired LD has been reported globally, and 
routine use of environmental cultures is recommended as a 
useful strategy to prevent infections (3). Although proac-
tive environmental surveillance of Legionella and regular 
treatment of cooling tower installations are recommended 
in many countries, these practices are not routine in India, 
and limited studies have been conducted in this country for 
monitoring Legionella contamination in hospital water sys-
tems (4). We conducted a study to detect L. pneumophila 
and to identify Lp1 in the water systems of a tertiary health-
care center in northern India that has organ transplantation 
and cancer treatment facilities.
We collected 79 water samples (41 potable, 38 non-
potable) from the hospital and general areas of the health-
care center during an 18-month period (May 2015–October 
2016). Of 79 samples, 27 were collected from patient areas 
(wards, intensive care units, outpatient departments, emer-
gency units, and procedure rooms); 14 from residential ar-
eas; 15 from cooling towers; and 23 from other buildings 
(e.g., laboratory divisions, teaching departments, library, 
and recreational zones). We followed guidelines issued by 
the US Centers for Disease Control and Prevention regard-
ing isolation of Legionella (5). In brief, we concentrated 
500 mL of water samples and decontaminated 1 part by 
using heat treatment (in water bath at 50°C for 30 min) 
and 1 part by acid (in equal volume of HCl-KCl acid buf-
fer [pH 2.2]). We then inoculated 0.1-mL samples onto 
buffered charcoal yeast extract agar (Becton Dickinson, 
Sparks, MD, USA) supplemented with glycine, vanco-
mycin, polymyxin B, and cycloheximide (Oxoid, Basing-
stoke, UK). We presumptively identified colonies growing 
only on buffered charcoal yeast extract but not on blood 
agar as Legionella species and confirmed the presence of 
L. pneumophila by amplification of a 375-bp region of the 
mip gene using previously published primers (6). We iden-
tified Lp1 by using a real-time PCR (rPCR) assay targeting 
the wzm gene (7). We used genomic DNA isolated from L. 
pneumophila strain Philadelphia (ATCC 33152) for stan-
dardization of PCR and rPCR and L. pneumophila strain 
Knoxville (ATCC 33153) for standardization of culture.
We identified Legionella spp. in 21 (26.6%) of 79 wa-
ter samples (10 potable and 11 nonpotable) by culture. We 
obtained a collection of 28 isolates from the 79 samples 
and identified all of them as L. pneumophila by PCR. 
Among these 28 isolates, 18 (64.3%) tested positive for 
Lp1 by rPCR, indicating the presence of this pathogenic 
serogroup in 12 (15.2%) of the 79 water samples (5 po-
table and 7 nonpotable).
We repeatedly isolated L. pneumophila (˃4 times) 
from 2 high-risk sites: a drinking water unit and a cool-
ing tower situated inside the hospital campus. Four wa-
ter samples collected from patient areas tested positive 
for L. pneumophila, posing a risk for nosocomial infec-
tion. We isolated L. pneumophila from water bodies with 
temperatures ranging from 12°C to 57°C but most frequent-
ly (11 times) from those with temperatures of 25°C–50°C. 
We summarized the isolation of L. pneumophila with 
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